For instance, biomarkers of type I, III, and VI collagen formation were reported to be elevated in patients with systemic sclerosis (SSc), and several growth factors and cytokines including TGF-β play a major role in stimulating collagen synthesis [46,47]. This evidence concerns the gene TGFB1 and systemic sclerosis.